Literature DB >> 10146912

Identifying drug usage patterns in the intensive care unit.

H J Mann1, E T Wittbrodt.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 10146912     DOI： 10.2165/00019053-199304040-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  12 in total

1.  Proactive review of biotechnological and other high-cost pharmaceuticals: a US approach.

Authors:  S A Iteen; S L Decker
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

Review 2.  Pharmacoeconomic aspects and formulary considerations related to histamine2-receptor antagonists.

Authors:  P F Souney; C A Stoukides
Journal:  DICP       Date:  1989-10

3.  Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient.

Authors:  V S Crane
Journal:  DICP       Date:  1990-11

4.  Rational use of antibiotics in the critically ill patient.

Authors:  J M Koeller
Journal:  DICP       Date:  1990-11

5.  Patterns of sedation and analgesia in the postoperative ICU patient.

Authors:  X Sun; T Quinn; C Weissman
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

6.  Drug use in a surgical intensive care unit.

Authors:  J F Dasta
Journal:  Drug Intell Clin Pharm       Date:  1986-10

7.  Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey.

Authors:  J H Hansen-Flaschen; S Brazinsky; C Basile; P N Lanken
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

8.  Antimicrobial misuse in patients with positive blood cultures.

Authors:  W C Dunagan; R S Woodward; G Medoff; J L Gray; E Casabar; M D Smith; C A Lawrenz; E Spitznagel
Journal:  Am J Med       Date:  1989-09       Impact factor: 4.965

9.  Drug use in a trauma intensive-care unit.

Authors:  B A Boucher; D A Kuhl; B C Coffey; T C Fabian
Journal:  Am J Hosp Pharm       Date:  1990-04

10.  Blood cultures and antibiotic use in a neonatal intensive care unit.

Authors:  M McDonald; A Moloney; T A Clarke; T G Matthews
Journal:  Ir J Med Sci       Date:  1992-01       Impact factor: 1.568
View more
  3 in total

1.  Full-cost determination of different levels of care in the intensive care unit. An activity-based costing approach.

Authors:  J J Doyle; J P Casciano; S R Arikian; J Mauskopf; J E Paul
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

2.  Evaluation of three brands of drug interaction software for use in intensive care units.

Authors:  Adriano Max Moreira Reis; Silvia Helena De Bortoli Cassiani
Journal:  Pharm World Sci       Date:  2010-10-21

3.  Assessing antibacterial pharmacoeconomics in the intensive care unit.

Authors:  M C Birmingham; J M Hassett; J J Schentag; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.